4//SEC Filing
ROCHE HOLDING LTD 4
Accession 0001104659-21-134647
CIK 0001689375other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 9:45 PM ET
Size
13.8 KB
Accession
0001104659-21-134647
Insider Transaction Report
Form 4
ROCHE FINANCE LTD
10% Owner
Transactions
- Conversion
Common Stock
2021-11-02+318,140→ 2,813,525 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2021-11-02−2,495,385→ 0 total(indirect: See Footnote)→ Common Stock (2,495,385 underlying) - Conversion
Common Stock
2021-11-02+2,495,385→ 2,495,385 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2021-11-02−318,140→ 0 total(indirect: See Footnote)→ Common Stock (318,140 underlying)
ROCHE HOLDING LTD
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2021-11-02−318,140→ 0 total(indirect: See Footnote)→ Common Stock (318,140 underlying) - Conversion
Common Stock
2021-11-02+318,140→ 2,813,525 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2021-11-02−2,495,385→ 0 total(indirect: See Footnote)→ Common Stock (2,495,385 underlying) - Conversion
Common Stock
2021-11-02+2,495,385→ 2,495,385 total(indirect: See Footnote)
Footnotes (2)
- [F1]Each share of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. These amounts reflect a 1-for- 7.235890014 reverse stock split which became effective on October 22, 2021. The Series A Preferred Stock and Series B Preferred Stock have no expiration date.
- [F2]Represents shares held by Roche Finance Ltd ("Roche Finance"). Roche Finance is a wholly owned subsidiary of Roche Holding Ltd ("Roche Holding"), a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding is the indirect beneficial owner of these securities of the Issuer. This Form 4 shall not be deemed an admission that any reporting person or other person is a beneficial owner of any securities of the Issuer for any purpose, other than the securities reported in this Form 4.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
IncorporatedSwitzerland
Related Parties
1- filerCIK 0000889131
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 9:45 PM ET
- Size
- 13.8 KB